Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

- PMLiVE

Novo pulls Tresiba from Europe’s biggest market

Firm’s new insulin will not be sold in Germany

- PMLiVE

Who is the marketer of the future?

How to prepare for biopharma marketing in 2020 and beyond

PEGASUS STRENGTHENS ITS PHARMA TEAM WITH TWO STAFF APPOINTMENTS

Pegasus shortlisted for three Communiqué awards and hopes to defend its Communications Consultancy of the Year win from 2014

Inizio

- PMLiVE

Vaccibody name Martin Bonde as CEO

He joins from EpiTherapeutics where he holds the same role

- PMLiVE

Drug and device firm doctor payments reach $6.5bn for 2014

1,444 companies made payments to around 600,000 physicians and 1,100 hospitals

- PMLiVE

Former Langland exec joins DJM Unlimited

Michael Le Brocq becomes the firm’s new director

Novartis day

Novartis heart drug may see novel pricing plan

Swiss firm looking to risk share with payers based on clinical outcomes

- PMLiVE

Roche and Evotec’s Alzheimer’s drug ineffective

Sembragiline failed to show cognitive and memory benefits

Pharma deals in June 2015

Allergan's $2.1bn acquisition of Kythera tops this month's deals

Great divides

The choices innovative companies make will lead to a fragmentary industry

- PMLiVE

Engaging patients in clinical trials

Multilingual, multimedia content is essentials of successful clinical trial communication

Celgene building

Celgene and Juno announce ten-year cancer deal

The firms’ pact will focus on the new area of immunotherapy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links